1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives
US6239147A · kind A · utility
4Cited by
4References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 17, 2000 |
| Grant date | May 29, 2001 |
| Priority date | — |
| Expiry date | May 17, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to novel 1-trifluoromethyl-4-hydroxy-7-piperidinylaminomethylchroman derivatives of the formula ##STR1## PA1 wherein R.sup.1 is C.sub.1 -C.sub.6 alkyl; PA1 R.sup.2 is hydrogen, C.sub.1 -C.sub.6 alkyl, halo C.sub.1 -C.sub.6 alkyl or phenyl; PA1 R.sup.3 is hydrogen or halo; and PA1 R.sup.4 and R.sup.5 are independently hydrogen, C.sub.1 -C.sub.6 alkyl or halo C.sub.1 -C.sub.6 alkyl, their pharmaceutically acceptable salts, pharmaceutical compositions containing such compounds, and the use of such compounds to treat CNS, gastrointestinal and other disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.